eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | atrial fibrillation |
| Comorbidity | C0040053|thrombosis |
| Sentences | 10 |
| PubMedID- 20082208 | Advanced age, low left atrial appendage velocity, and factor v promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation. |
| PubMedID- 19178964 | Background: the association between inflammatory status and thrombosis in patients with atrial fibrillation (af) is unclear. |
| PubMedID- 24681012 | Radiotherapy and prevention of thrombosis in a patient with atrial fibrillation. |
| PubMedID- 21925716 | This study investigated the antithrombotic effect of azd0837, compared to ximelagatran and the vitamin k antagonist (vka) phenprocoumon (marcoumar), in a disease model of thrombosis in patients with non-valvular atrial fibrillation (nvaf). |
| PubMedID- 23411574 | Because the left atrial appendix (laa) is the most common place of thrombosis formation in patients with atrial fibrillation (af) and mitral stenosis (ms), it can easily be excluded from the systemic circulation at the time of cardiac surgery by excision, ligation, suturing, or stapling. |
| PubMedID- 23026659 | Orally active direct inhibitors of thrombin and factor xa have now been approved for treatment or prevention of deep vein thrombosis,and stroke associated with atrial fibrillation. |
| PubMedID- 24057604 | Abo blood group and risk of peripheral arterial thrombosis in patients with atrial fibrillation: a single center survey. |
| PubMedID- 21828929 | Triple-chamber cardiac thrombosis in a patient with atrial fibrillation and severe left ventricular dysfunction. |
| PubMedID- 25861354 | Warfarin is a common anticoagulant agent that is used in various cardiovascular diseases, venous thrombosis, prevention of systematic embolism, atrial fibrillation, and cardiac valve diseases [1]. |
| PubMedID- 23023369 | It is approved in the united states for the prophylaxis of deep vein thrombosis and stroke in patients with atrial fibrillation; however, it also carries a black box warning regarding the risk of thrombosis after discontinuation of treatment. |
Page: 1